The Palliative Care Needs of Patients with Multiple Sclerosis, Parkinson's Related Diseases, and Motor Neurone Disease: A Secondary Analysis of the OPTCARE Neuro Trial Data

被引:0
|
作者
Doherty, Mairead [1 ,3 ]
Chukwusa, Emeka [2 ]
McQuillan, Regina [1 ]
Cranfield, Faith [1 ]
Gao, Wei [2 ]
机构
[1] St Francis Hosp, Dublin, Ireland
[2] Kings Coll London, Cicely Saunders Inst Palliat Care Policy & Rehabil, London, England
[3] St Francis Hosp, Palliat Med, Dublin 15, Ireland
关键词
cross-sectional studies; motor neurone disease; multiple sclerosis; neurology; palliative care; Parkinson's disease; patient-reported outcome measures; AMYOTROPHIC-LATERAL-SCLEROSIS; NEUROLOGICAL CONDITIONS; HOSPITAL ANXIETY; RATING-SCALES; DEPRESSION; VALIDATION; RELIABILITY; EXPERIENCES; PREVALENCE; DISORDERS;
D O I
10.1089/jpm.2023.0437
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Long-term neurological conditions include multiple sclerosis, Parkinson's-related diseases, and motor neurone disease. National and international guidelines recommend a palliative approach for advancing neurological disease, but there is little research describing and comparing the palliative care needs of these patients side by side.Objective: The aim of this study was to describe and compare the symptom burden and psychological distress of patients with multiple sclerosis, Parkinson's-related diseases, and motor neurone disease.Design: A cross-sectional secondary analysis of the OPTCARE Neuro trial data was performed.Setting/Subjects: Recruitment was from seven sites across the United Kingdom. Patients aged 18 years or older, severely affected by advanced stages of multiple sclerosis or Parkinson's-related diseases or any stage of motor neurone disease, with an unresolved symptom, and one other issue despite usual care were eligible.Measurements: Baseline demographics, Integrated Palliative care Outcome Scale (IPOS) Neuro, and Hospital Anxiety and Depression Scale (HADS) results were analyzed.Results: Data from 348 participants were analyzed. The mean IPOS Neuro-S24 score was 27, with no statistical difference found between groups (p = 0.341). The most common symptoms were poor mobility (68.5%), problems using legs (63%), and fatigue (34.8%). The HADS revealed that a quarter of participants met the criteria for a diagnosis of anxiety and depression.Conclusions: Multiple sclerosis, Parkinson's-related disease, and motor neurone disease patients who were eligible for the OPTCARE Neuro trial have unmet needs in the form of distressing physical and psychological symptoms. It is unclear how to address these needs. The answer likely lies in a collaborative approach between neurology, palliative care, psychology, and specialized allied health professionals. Future work should focus on investigating this.
引用
收藏
页码:622 / 629
页数:8
相关论文
共 23 条
  • [1] Palliative care in multiple sclerosis and motor neurone disease
    Barnes, Julia
    Campbell, Colin
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (01) : 21 - 25
  • [2] Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: A population-based study
    Sleeman, Katherine E.
    Ho, Yuen K.
    Verne, Julia
    Glickman, Myer
    Silber, Eli
    Gao, Wei
    Higginson, Irene J.
    PALLIATIVE MEDICINE, 2013, 27 (09) : 840 - 846
  • [3] The palliative care needs and experiences of patients with advanced Parkinson's disease: a qualitative scoping review
    Lou, Yan
    Li, Yiting
    Chen, Yiping
    FRONTIERS IN MEDICINE, 2024, 11
  • [4] Predictors of activity and participation across neurodegenerative conditions: a comparison of people with motor neurone disease, multiple sclerosis and Parkinson’s disease
    David Morley
    Sarah Dummett
    Laura Kelly
    Ray Fitzpatrick
    Crispin Jenkinson
    BMC Neurology, 18
  • [5] Predictors of activity and participation across neurodegenerative conditions: a comparison of people with motor neurone disease, multiple sclerosis and Parkinson's disease
    Morley, David
    Dummett, Sarah
    Kelly, Laura
    Fitzpatrick, Ray
    Jenkinson, Crispin
    BMC NEUROLOGY, 2018, 18
  • [6] Palliative and end-of-life care in advanced Parkinson's disease and multiple sclerosis
    Campbell, Colin W.
    Jones, Edward J. S.
    Merrills, Jane
    CLINICAL MEDICINE, 2010, 10 (03) : 290 - 292
  • [7] Motor data analysis of Parkinson's disease patients
    Fiska, Vasiliki
    Giannakeas, Nikolaos
    Katertsidis, Nikolaos
    Tzallas, Alexandros T.
    Kalafatakis, Konstantinos
    Tsipouras, Markos G.
    2020 IEEE 20TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOENGINEERING (BIBE 2020), 2020, : 946 - 950
  • [8] Experiences of burden, needs, rewards and resilience in family caregivers of people living with Motor Neurone Disease/Amyotrophic Lateral Sclerosis: A secondary thematic analysis of qualitative interviews
    Weisser, Fabia B.
    Bristowe, Katherine
    Jackson, Diana
    PALLIATIVE MEDICINE, 2015, 29 (08) : 737 - 745
  • [9] Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders A Randomized Clinical Trial
    Kluger, Benzi M.
    Miyasaki, Janis
    Katz, Maya
    Galifianakis, Nicholas
    Hall, Kirk
    Pantilat, Steven
    Khan, Ryan
    Friedman, Cari
    Cernik, Wendy
    Goto, Yuika
    Long, Judith
    Fairclough, Diane
    Sillau, Stefan
    Kutner, Jean S.
    JAMA NEUROLOGY, 2020, 77 (05) : 551 - 560
  • [10] High Correlations Among Worldwide Prevalences of Dementias, Parkinson's Disease, Multiple Sclerosis, and Motor Neuron Diseases Indicate Common Causative Factors
    James, Lisa M.
    Georgopoulos, Apostolos P.
    NEUROSCIENCE INSIGHTS, 2022, 17